EZH2 is a negative prognostic biomarker associated with immunosuppression in hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0242191
Abstract: The enhancer of zeste homolog 2 (EZH2) plays a critical role in different components of anti-tumor immunity. However, the specific role of EZH2 in modulating MHC Class I antigen presentation and T cell infiltration have… read more here.
Keywords: negative prognostic; ezh2; ezh2 negative; expression ... See more keywords